Recent advances in the molecular understanding of glioblastoma

Por Bleeker, Fonnet E., Molenaar, Remco J., Leenstra, Sieger
Publicado em 2012

Absence of AKT1 Mutations in Glioblastoma

Por Bleeker, Fonnet E., Lamba, Simona, Zanon, Carlo, van Tilborg, Angela A., Leenstra, Sieger, Troost, Dirk, Hulsebos, Theo, Vandertop, W. Peter, Bardelli, Alberto
Publicado em 2009

Mutational Profile of GNAQ (Q209) in Human Tumors

Por Lamba, Simona, Felicioni, Lara, Buttitta, Fiamma, Bleeker, Fonnet E., Malatesta, Sara, Corbo, Vincenzo, Scarpa, Aldo, Rodolfo, Monica, Knowles, Margaret, Frattini, Milo, Marchetti, Antonio, Bardelli, Alberto
Publicado em 2009

The prognostic IDH1(R132) mutation is associated with reduced NADP(+)-dependent IDH activity in glioblastoma

Por Bleeker, Fonnet E., Atai, Nadia A., Lamba, Simona, Jonker, Ard, Rijkeboer, Denise, Bosch, Klazien S., Tigchelaar, Wikky, Troost, Dirk, Vandertop, W. Peter, Bardelli, Alberto, Van Noorden, Cornelis J. F.
Publicado em 2010

Mutational profiling of kinases in glioblastoma

Por Bleeker, Fonnet E, Lamba, Simona, Zanon, Carlo, Molenaar, Remco J, Hulsebos, Theo JM, Troost, Dirk, van Tilborg, Angela A, Vandertop, W Peter, Leenstra, Sieger, van Noorden, Cornelis JF, Bardelli, Alberto
Publicado em 2014

Molecular Profiling of the ‘Plexinome’ in melanoma and pancreatic cancer

Por Balakrishnan, Asha, Penachioni, Junia Y., Lamba, Simona, Bleeker, Fonnet E, Zanon, Carlo, Rodolfo, Monica, Vallacchi, Viviana, Scarpa, Aldo, Felicioni, Lara, Buck, Matthias, Marchetti, Antonio, Comoglio, Paolo M., Bardelli, Alberto, Tamagnone, Luca
Publicado em 2009

Differential Activity of NADPH-Producing Dehydrogenases Renders Rodents Unsuitable Models to Study IDH1(R132) Mutation Effects in Human Glioblastoma

Por Atai, Nadia A., Renkema-Mills, Nynke A., Bosman, Joost, Schmidt, Nadja, Rijkeboer, Denise, Tigchelaar, Wikky, Bosch, Klazien S., Troost, Dirk, Jonker, Ard, Bleeker, Fonnet E., Miletic, Hrvoje, Bjerkvig, Rolf, De Witt Hamer, Philip C., Van Noorden, Cornelis J. F.
Publicado em 2011

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone

Por Molenaar, Remco J., Verbaan, Dagmar, Lamba, Simona, Zanon, Carlo, Jeuken, Judith W.M., Boots-Sprenger, Sandra H.E., Wesseling, Pieter, Hulsebos, Theo J.M., Troost, Dirk, van Tilborg, Angela A., Leenstra, Sieger, Vandertop, W. Peter, Bardelli, Alberto, van Noorden, Cornelis J.F., Bleeker, Fonnet E.
Publicado em 2014

Validation of a clinical screening instrument for tumour predisposition syndromes in patients with childhood cancer (TuPS): protocol for a prospective, observational, multicentre s...

Por Postema, Floor A M, Hopman, Saskia M J, de Borgie, Corianne A J M, Hammond, Peter, Hennekam, Raoul C, Merks, Johannes H M, Aalfs, Cora M, Anninga, Jakob K, Berger, Lieke PV, Bleeker, Fonnet E, de Bont, Eveline SJM, de Borgie, Corianne AJM, Dommering, Charlotte J, van Eijkelenburg, Natasha KA, Hammond, Peter, Hennekam, Raoul C, van den Heuvel-Eibrink, Marry M, Hopman, Saskia MJ, Jongmans, Marjolijn CJ, Kors, Wijnanda A, Letteboer, Tom GW, Loeffen, Jan LCM, Merks, Johannes HM, Olderode-Berends, Maran JW, Postema, Floor AM, Wagner, Anja
Publicado no BMJ Open (2017)